---
title: "Tumori: immunoterapico tislelizumab approvato da Aifa per cancro a esofago, stomaco e polmone"
description: Your browser does not support the video tag.
featured_image: https://laragione.eu/wp-content/uploads/adnkronos-images/20261205_1915_SERVIZIO_GRAFICATO_INTERMEDIA_BEONE_LEANEWS_video-hd-1024x576.jpg
date: 2026-05-13
author: adnkronos
url: https://laragione.eu/adnkronos/video-adnkronos/tumori-immunoterapico-tislelizumab-approvato-da-aifa-per-cancro-a-esofago-stomaco-e-polmone/
categories: [Video]
---

# Tumori: immunoterapico tislelizumab approvato da Aifa per cancro a esofago, stomaco e polmone

![Tumori: immunoterapico tislelizumab approvato da Aifa per cancro a esofago, stomaco e polmone](https://laragione.eu/wp-content/uploads/adnkronos-images/20261205_1915_SERVIZIO_GRAFICATO_INTERMEDIA_BEONE_LEANEWS_video-hd-1024x576.jpg)

Your browser does not support the video tag.